Cardiac sodium channel diseases

Clinical Chemistry and Laboratory Medicine

Volumn 41, Issue 4, 2003, Pages 439-444

  Napolitano, Carlo ^a   Rivolta, Ilaria ^a   Priori, Silvia G ^a,b  

^a IRCCS   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Cardiac sodium channel; Long QT syndrome; Sudden death

Indexed keywords

AMINO ACID; SODIUM CHANNEL; SODIUM ION;

ALLELE; AMINO ACID SUBSTITUTION; BRUGADA SYNDROME; CLINICAL FEATURE; DISEASE CLASSIFICATION; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HEART ARRHYTHMIA; HEART DISEASE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE EXCITABILITY; HUMAN; IN VITRO STUDY; LONG QT SYNDROME; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SUDDEN DEATH;

HEART DISEASES; HUMANS; MUTATION; POLYMORPHISM, GENETIC; SODIUM CHANNELS;

EID: 0038059082     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2003.066     Document Type: Review

References (46)

1. Schwartz PJ, Priori SG, Napolitano C. The long QT syndrome. In: Zipes DP, Jalife J, editors. Cardiac electrophysiology. From cell to bedside. Philadelphia: WB Saunders Co., 2000:597-615.
2. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995; 80:805-11.
3. Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998; 392:293-6.
4. Schott JJ, Alshinawi C, Kyndt F, Probst V, Hoorntje TM, Hulsbeek M, et al. Cardiac conduction defects associate with mutations in SCN5A. Nat Genet 1999; 23:20-1.
5. Gellens ME, George AL Jr, Chen LQ, Chahine M, Horn R, Barchi RL, et al. Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel. Proc Natl Acad Sci USA 1992; 89:554-8.
6. George AL, Jr., Varkony TA, Drabkin HA, Han J, Knops JF, Finley WH, et al. Assignment of the human heart tetrodotoxin-resistant voltage-gated Na+ channel alpha-subunit gene (SCN5A) to band 3p2l. Cytogenet Cell Genet 1995; 68:67-70.
7. An RH, Wang XL, Kerem B, Benhorin J, Medina A, Goldmit M, et al. Novel LQT-3 mutation affects Na+ channel activity through interactions between alpha- and beta1-subunits. Circ Res 1998; 83:141-6.
8. Kupershmidt S, Yang T, Roden DM. Modulation of cardiac Na+ current phenotype by beta1-subunit expression. Circ Res 1998; 83:441-7.
9. Cormier JW, Rivolta I, Tateyama M, Yang AS, Kass RS. Secondary structure of the human cardiac Na+ channel C terminus: evidence for a role of helical structures in modulation of channel inactivation. J Biol Chem 2002; 277: 9233-41.
10. Jiang C, Atkinson D, Towbin JA, Splawski I, Lehmann MH, Li H, et al. Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. Nat Genet 1994; 8:141-7.
11. Wang DW, Yazawa K, George AL Jr, Bennett PB. Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome. Proc Natl Acad Sci USA 1996; 93:13200-5.
12. Wattanasirichaigoon D, Vesely MR, Duggal P, Levine JC, Blume ED, Wolff GS, et al. Sodium channel abnormalities are infrequent in patients with long QT syndrome: identification of two novel SCN5A mutations. Am J Med Genet 1999; 86:470-6.
13. Bezzina C, Veldkamp MW, van Den Berg MP, Postma AV, Rook MB, Viersma JW, et al. A single Na(+) channel mutation causing both long-QT and Brugada syndromes. Circ Res 1999; 85:1206-13.
14. Priori SG, Napolitano C, Terreni L, Crotti L, De Feo S, Drago F, et al. Unexpected phenotypic heterogeneity an prevalence of LQT3 [abstract]. Circulation 1999; (abs suppl) 80.
15. Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, et al. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med 1998; 339:960-5.
16. Bennett PB, Yazawa K, Makita N, George AL Jr Molecular mechanism for an inherited cardiac arrhythmia. Nature 1995; 376:683-5.
17. Rivolta I, Abriel H, Tateyama M, Liu H, Memmi M, Vardas P, et al. Inherited Brugada and LQT-3 syndrome mutations of a single residue of the cardiac sodium channel confer distinct channel and clinical phenotypes. J Biol Chem 2001; 276:30623-30.
18. Ackerman MJ, Siu BL, Sturner WQ, Tester DJ, Valdivia CR, Makielski JC, et al. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. J Am Med Assoc 2001; 286:2264-9.
19. Wedekind H, Smits JPP, Schulze-Bahr E, Arnold R, Veldkamp MW, Bajanowski T, et al. De Novo mutation in the SCN5A gene associated with early onset of sudden infant death. Circulation 2001; 104:1158-64.
20. Shirai N, Makita N, Sasaki K, Yokoi H, Sakuma I, Sakurada H, et al. A mutant cardiac sodium channel with multiple biophysical defects associated with overlapping clinical features of Brugada syndrome and cardiac conduction disease. Cardiovasc Res 2002; 53:348-54.
21. Brugada J, Brugada R, Brugada P. Brugada syndrome. Arch Mal Coeur Vaiss 1999; 92:847-50.
22. Priori SG, Napolitano C, Gasparini M, Pappone C, Della BP, Brignole M, et al. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: a prospective evaluation of 52 families. Circulation 2000; 102:2509-15.
23. Atarashi H, Ogawa S, Harumi K, Sugimoto T, Inoue H, Murayama M, et al. Three-year follow-up of patients with right bundle branch block and ST segment elevation in the right precordial leads: Japanese Registry of Brugada Syndrome. Idiopathic Ventricular Fibrillation Investigators. J Am Coll Cardiol 2001; 37:1916-20.
24. Takenaka S, Kusano KF, Hisamatsu K, Nagase S, Nakamura K, Morita H, et al. Relatively benign clinical course in asymptomatic patients with Brugada-type electrocardiogram without family history of sudden death. J Cardiovasc Electrophysiol 2001; 12:2-6.
25. Brugada J, Brugada R, Brugada P. Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. Circulation 1998; 97:457-60.
26. Weiss R, Barmada MM, Nguyen T, Seibel JS, Cavlovich D, Kornblit CA, et al. Clinical and molecular heterogeneity in the Brugada syndrome: a novel gene locus on chromosome 3. Circulation 2002; 105:707-13.
27. Vatta M, Dumaine R, Varghese G, Richard TA, Shimizu W, Aihara N, et al. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet 2002; 11:337-45.
28. Wang DW, Makita N, Kitabatake A, Balser JR, George AL Jr. Enhanced Na(+) channel intermediate inactivation in Brugada syndrome. Circ Res 2000; 87:E37-E43.
29. Abriel H, Cabo C, Wehrens XH, Rivolta I, Motoike HK, Memmi M, et al. Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel. Circ Res 2001; 88:740-5.
30. Wan X, Chen S, Sadeghpour A, Wang Q, Kirsch GE. Accelerated inactivation in a mutant Na(+) channel associated with idiopathic ventricular fibrillation. Am J Physiol Heart Circ Physiol 2001; 280:H354-H360.
31. Baroudi G, Pouliot V, Denjoy I, Guicheney P, Shrier A, Chahine M. Novel mechanism for Brugada syndrome: defective surface localization of an SCN5A mutant (R1432G). Circ Res 2001; 88:E78-E83.
32. Lenegre J. Etiology and pathology of bilateral bundle branch block in relation to complete heart block. Prog Cardiovasc Dis 1964; 6:409-44.
33. Lev M, Kinare SG, Pick A. The pathogenesis of atrioventricular block in coronary disease. Circulation 1970; 42: 409-25.
34. Tan HL, Bink-Boelkens MT, Bezzina CR, Viswanathan PC, Beaufort-Krol GC, van Tintelen PJ, et al. A sodium-channel mutation causes isolated cardiac conduction disease. Nature 2001; 409:1043-7.
35. Clancy CE, Kass RS. Defective cardiac ion channels: from mutations to clinical syndromes. J Clin Invest 2002; 110:1075-7.
36. Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996; 27:1061-70.
37. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (Online) 2001; 103:89-95.
38. Schwartz PJ, Priori SG, Locati EH, Napolitano C, Cantu F, Towbin JA, et al. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation 1995; 92:3381-6.
39. Clancy CE, Rudy Y. Na(+) channel mutation that causes both Brugada and long-QT syndrome phenotypes: a simulation study of mechanism. Circulation 2002; 105:1208-13.
40. Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 1999; 100: 1660-6.
41. Grant AO, Carboni MP, Neplioueva V, Starmer CF, Memmi M, Napolitano C, et al. Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation. J Clin Invest 2002; 110: 1201-9.
42. Priori SG. Foretelling the future in Brugada syndrome: do we have the crystal ball? J Cardiovasc Electrophysiol 2001; 12:1008-9.
43. Kyndt F, Probst V, Potet F, Demolombe S, Chevallier JC, Baro I, et al. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation 2001; 104:3081-6.
44. Priori SG, Napolitano C, Schwartz PJ, Bloise R, Crotti L, Ronchetti E. The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge. Circulation 2000; 102:945-7.
45. Splawski I, Timothy KW, Tateyama M, Clancy CE, Malhotra A, Beggs AH, et al. Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science 2002; 297:1333-6.
46. Ye B, Valdivia CR, Ackerman MJ, Makielski JC. A common human SCN5A polymorphism modifies expression of an arrhythmia causing mutation. Physiol Genomics 2003; 12: 187-93.